| Autor: |
Ighilahriz, M, Benfodda, M, Sharpe, H, Soufir, N, Mourah, S, Dumaz, N, Battistella, M, Savina, A, Bouquet, F, Nikolaev, S, Basset-Seguin, N |
| Přispěvatelé: |
Basset-Seguin, N [0000-0002-9136-1244], Apollo - University of Cambridge Repository |
| Rok vydání: |
2019 |
| Předmět: |
|
| DOI: |
10.17863/cam.41803 |
| Popis: |
Hedgehog pathway inhibitors (HPI) inactivating SMO 1, have become first line treatment for patients with locally advanced BCC (laBCC). HPI safety and efficacy have been shown in clinical trials2,3. Nevertheless, common adverse events lead to treatment discontinuation. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
